(Q44490305)

3 December 2017

Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer (English)

1 reference

3 December 2017

0 references

Yasushi Yamada

1

1 reference

3 December 2017

Masatoshi Watanabe

2

1 reference

3 December 2017

Mikio Yamanaka

3

1 reference

3 December 2017

Yoshifumi Hirokawa

4

1 reference

3 December 2017

Hiroyoshi Suzuki

5

1 reference

3 December 2017

Akimitsu Takagi

6

1 reference

3 December 2017

Takeshi Matsuzaki

7

1 reference

3 December 2017

Yoshiki Sugimura

8

1 reference

3 December 2017

Ryuichi Yatani

9

1 reference

3 December 2017

Taizo Shiraishi

10

1 reference

3 December 2017

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

94

1 reference

3 December 2017

536-539

1 reference

3 December 2017

6

1 reference

Cancer epigenetics comes of age

3 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

COBRA: a sensitive and quantitative DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Reactivating the expression of methylation silenced genes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

Expression of vascular endothelial growth factor receptors in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01479.X

10.1111/J.1349-7006.2003.TB01479.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference